We’ve been so busy on the project that we’ve neglected updating the website – apologies. As of 17 November 2017:
Phase 1 has now been completed. We have gathered data from 16 sites, involving 1,326 patients and 2,008 infusions. This took considerably longer to organise and collect than we had expected, and the data had to be cleaned so it was consistent across our 16 sites, e.g. so error ratings were comparable. We have submitted two papers and have a further two in draft form. One of the highlights of this phase of the project was feeding back results to sites – we prepared a report on the data for each site and held debriefs and focus groups to discuss this at those sites. This served well to give further detail about errors and the infusion practices at each site, and some sites planned to act on the results by reviewing policy, training and purchasing equipment to help nurses in their work.
Phase 2 involves deeper observations at 5 sites involved in Phase 1. Four of these sites have been completed the fifth will commence soon. We plan to develop papers on the error inducing factors that we have observed at this stage, and the positive deviations in practices too.
Phase 3 involves reaching our to stakeholders of intravenous infusion administration. We have been disseminating our emerging findings at conferences that clinicians and hospital management have been attending throughout the project. The latter stages of phase 3 involve organising three workshops, one with manufacturers, one with NHS stakeholders and one with patients and the public. We will be organising these shortly.
The project’s steering committee and advisory groups have met several times and have provided us with great guidance and feedback throughout.
To summarise, there should be some more published findings to share soon, we have some key research activities that are still to be do, and we need to draw all of this together for the end of March 2018 – so there’s still a lot to do but we’re making great progress.
As we come to the end of Phase 1 we wanted some feedback on our emerging results and project plans. We presented analysis on 9 of our 16 sites to our Advisory Group and held breakout sessions on specific topics:
- How should we interpret the point prevalence data? What are the implications for practice/policy?
- What, if anything, do we do about the variability in practices and policies discussed in focus groups in Phase 1? How do we practically identify best practice(s)?
- How can we best disseminate our findings for maximum positive impact?
It was great to get input from the stakeholders that form our Advisory Group, which we will feed into our future project plans, reports and publications.
Research Associate: observational studies of infusion device use across multiple hospitals
Starting Salary (Grade 7), currently £33,686-34,604 inclusive of London Allowance
Applications are invited for the post of Post-doctoral Research Associate in the UCL Interaction Centre to work under the supervision of Prof. Ann Blandford and with other members of the ECLIPSE project team. The aim of the studies is to make intravenous infusion devices safer.
The successful candidate will work with clinicians and patients to run a series of observational studies on the use of infusion devices in hospitals. These will involve detailed observations in selected wards to better understand the causes and consequences of deviations from clinical protocol when delivering intravenous medications. Throughout the project, we will be working with hospital staff and policy makers to identify best practices and develop guidance on the selection and deployment of infusion devices and the delivery of infusion therapies. The postholder will also be expected to contribute to the writing of manuscripts and presentation of the data at conferences.
The post is available to start from 18th July 2016 or as soon as possible after that. The post is available until 30th June 2017 in the first instance.
Applicants should have obtained a PhD in a relevant subject (e.g., pharmacy, nursing or Human–Computer Interaction). Ideal candidates will have a strong background in qualitative research methods and experience of working in healthcare. Applicants should have demonstrated potential for excellent research (e.g., as evidenced by their publication track record in international journals) and the capability and motivation to collaborate within an interdisciplinary research group. The ability to work as part of a research team is essential.
For instructions on how to apply, and for a job description and person specification, please go to https://atsv7.wcn.co.uk/search_engine/jobs.cgi?owner=5041178&ownertype=fair&jcode=1551193. Information about the ECLIPSE project is available from http://www.eclipse.ac.uk/.
Informal enquiries about the post can be made to Professor Ann Blandford (email@example.com) or Dr Dominic Furniss (D.Furniss@ucl.ac.uk). Enquiries about the application process should be made to Dr Louise Gaynor (firstname.lastname@example.org).
Closing date for applications is Friday 10th June 2016. Interviews will be held on Monday 27th June 2016.
UCL Taking Action For Equality
We have now delivered training at four hospitals taking part in the point prevalence study and have had the pleasure of meeting many engaged and enthusiastic researchers and clinicians around the country who will be helping us with the study.
The half-day training sessions cover the study protocol, the data collection procedures and documentation, and using REDCap software for data entry. Where feasible the training has involved a practical session allowing data collectors to undertake some trial observations and get a feel for the data entry system. The data collectors have reported finding this helpful to get a better understanding of how the study will work in practice.
At each hospital those participating in the training have asked thoughtful questions, raised interesting issues for discussion and offered useful feedback, helping us to further refine our data collection tools, and improve our training materials and guidance. We are also capturing this learning in a Hints, Tips and Frequently Asked Questions sheet to ensure that each of our sites benefits from others’ experiences and ideas.
We are looking forward to further data collection at these sites, and to visiting more hospitals for training over the coming months.
We have started data collection and entry at our first site, which is going well. We have identified some interesting examples of minor deviations from local policy that have provoked debate among the ECLIPSE team regarding their significance and are highlighting the complexities of real life clinical practice.
We are using our experiences at this first site to review our data collection guidance for further sites. We are also creating a Hints, Tips & Frequently Asked Questions sheet for knowledge sharing between sites, and we’re creating a guide with examples of how to classify different discrepancies and errors to ensure consistent reporting across sites.
At our first site, we have found that our two data collectors are working together well as a team, with one recording the data on the collection forms, while the other looks at the infusions in place. When entering the data into the database, the observer who completed the forms then calls out the data and the other observer enters it. We have found this gives us a consistent approach and works well with the design of the data collection forms and the database.